About IVIEW Therapeutics
IVIEW Therapeutics is a private company based in Cranbury, New Jersey. It has reported $39,204,816 raised in two offerings on Form D since March 2021. Its chief executive is Bo Liang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 14, 2024 | May 24, 2024amended Jun 10, 2025 | $9,177,371of $15.0M target | 5 | $1.8M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Feb 26, 2021 | Mar 12, 2021amended Jan 12, 2022 | $30,027,445fully sold | 15 | $2.0M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $39,204,816 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on IVIEW Therapeutics's Form D filed Jun 10, 2025.
QZ
Qi Zhu
Director
HH
Houman Hemmati
Executive officer and director
WW
Wei Wang
Executive officer and director
JL
Jingjie Li
Director
XS
Xiaolu Sun
Director
BL
Bo Liang
Chief Executive Officer and director
BH
Bin He
Director
Earlier filings also listed Tao Du (director, last listed Jan 2022) and John Baldwin (director, last listed Jan 2022).